Nyxoah SA (NYXH)
8.00
-0.28
(-3.38%)
USD |
NASDAQ |
Nov 22, 16:00
7.99
-0.01
(-0.12%)
After-Hours: 20:00
Nyxoah Profit Margin (Quarterly): -1.35K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.35K% |
| June 30, 2024 | -1.70K% |
| March 31, 2024 | -975.1% |
| December 31, 2023 | -597.2% |
| September 30, 2023 | -779.9% |
| June 30, 2023 | -1.16K% |
| March 31, 2023 | -2.70K% |
| December 31, 2022 | -1.02K% |
| Date | Value |
|---|---|
| September 30, 2022 | -3.43K% |
| June 30, 2022 | -533.1% |
| March 31, 2022 | -1.02K% |
| December 31, 2021 | -2.12K% |
| September 30, 2021 | -4.32K% |
| June 30, 2021 | -4.08K% |
| March 31, 2021 | -3.06K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.32K%
Minimum
Sep 2021
-533.1%
Maximum
Jun 2022
-1.92K%
Average
-1.35K%
Median
Sep 2024
Profit Margin (Quarterly) Benchmarks
| Galapagos NV | -84.26% |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Celyad Oncology SA | -- |
| MDxHealth SA | -47.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.10% |
| Return on Assets | -39.96% |
| Return on Invested Capital | -46.13% |
| Gross Profit Margin (Quarterly) | 61.93% |
| Operating Margin (Quarterly) | -1.18K% |
| Return on Net Operating Assets | -73.18% |